Clinical assessment of patients with evolving acute myocardial infarction may suggest recanalizatim of the infarct coronary artery if chest pain, electrocardiographic ST-segment elevation and reperfusion arrhythmia are dimlnished. These 3 criteria, however, have not been correlated with immediate coronary angiography. Determination of which patients will achieve myocardial reperfusion after intravenous fibrinolytic therapy would allow for appropriate triage; those in whom it fails may be considered for mechanical or surgical recanalization. Fifty-six patients were studied: 28 received intravenous streptokinase and 28 intravenous recombinant tissue-type plasminogen activator. None of these clinical criteria, considered separately, was predictive of infarct artery recanalization status. Using the presence or absence of all 3 criteria, the specificity and predictive value increased to 100 % . However, only 9% of patients in the series had all 3 criteria present (all had a patent infarct artery) and 34% had no criteria present (all had an occluded vessel). Nonlnvasive clinical markers are simple and practical, but only concordance of all 3 major criteria, when present, accurately predicts resutts of thrombolytic therapy.
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E arly intravenous fibrinolytic therapy in acute myocardial infarction (AMI) has been shown to reduce mortality risk? Using the thrombolytic agents available or under investigation, a 50 to 75% infarct-vessel recanalization rate can be expected.3-7 The 25 to 50% of patients in whom thrombolytic therapy fails remain candidates for urgent mechanical recanalization of the occluded artery with percutaneous transluminal coronary angiplasty. This alternative therapy has been shown to promote myocardial functional recovery.s*g If one could quickly and reliably predict which patients will respond favorably to intravenous thrombolysis, the need for emergency cardiac catheterization and PTCA might be obviated in some patients. Three clinical criteria have been proposed as markers for myocardial reperfusion: reduction of chest discomfort, improvement of electrocardiographic ST-segment elevation and reperfusion arrhythmias.lO Despite their common usage in assessing patients who receive thrombolytic therapy, these criteria have not been evaluated in relation to immediate arteriographic findings. The present study is the first prospective demonstration of the predictive value of these criteria for infarct-vessel recanalization after intravenous thrombolytic therapy.
Methods
Fifty-six consecutive patients who received intravenous thrombolytic therapy for transmural AMI, with less than 6 hours of chest pain, were studied. All patients had at least 2 mm of ST-segment elevation in 2 or more contiguous electrocardiographic leads before initiation of treatment. Intravenous streptokinase, at a dose of 1.5 million units over 30 minutes, was given to 28 patients and intravenous human tissue-type plasminogen activator, at 1.25 mg/kg over 3 hours, was administered to 28. The following data were prospectively collected before and 90 minutes after thrombolytic therapy: (1) change in chest discomfort intensity on a subjective scale from 0 to 10, with a decrease of at least 2 representing improvement:
(2) electrocardiographic ST-segment elevation averaged in the 2 contiguous leads showing maximal elevation in a la-lead tracing; and (3) reperfusion arrhythmia, defined as an arrhythmia noted during the go-minute period of administering thrombolytic therapy. The following arrhythmias were considered suggestive of reperfusion: accelerated idioventricular or junctional rhythm, paroxysmal sinus bradycardia (less than SO beats/min) second-or third-degree atrioventricular block, ventricular tachycardia (at least 3 beats] and ventricular fibrillation. At 90 minutes after the initiation of thrombolytic therapy, patients underwent selective coronary arteriography through the transfemoral approach. All patients received 5,000 U of heparin after arterial access was obtained. No intracoronary nitroglycerin was administered before the first infarct-vessel angiogram. This angiogram was used to grade infarct-vessel patency according to criteria from the Thrombolysis in Myocardial Infarction trial [grade 2 or 3 = patency),*1 independent of the clinical data.
To determine the predictive value for each of the clinical criteria and combinations of these criteria, sensitivity, specificity and predictive value'was calculated as follows: Sensitivity = number of patients with patent artery and reperfusion criteria present/number of patients with patent vessel. Specificity = number of patients with occluded artery and without reperfusion criteria present/number of patients with occluded vessel.
Predictive value = number of patients with patent artery and reperfusion criteria/number of patients with reperfusion criteria.
Results
Of the 56 patients studied, 44 were men and 12 women, mean age 56 f 9 years. The time from onset of chest pain to thrombolytic therapy was 3.1 f 09 hours and from chest pain to cardiac catheterization 4.2 f 1.2 hours. The infarct-related artery was the left anterior descending in 24 patients, the left circumflex in 7 and the right coronary artery in 25. Recanalization occurred in 37 of the 56 patients (66%) in this series. Table I lists the percentage of patients in whom each of the 3 major reperfusion criteria were present compared with recanalization status, expressed as sensitivity, specificity and predictive value. The sensitivity and specificity were not adequate for ST segment and arrhythmia considered separately [ Table I ). The sensitivity and predictive value of chest pain, improvement was 61% and 64%. respectively. By combining a decrease in chest discomfort and ST-segment improvement, a higher specificity and predictive value were achieved. Using all 3 criteria, a predictive value of 100% was found. However, this resulted in only 5 of 37 patients (14% sensitivity] who had confirmed angiographic patency having all 3 criteria present. In contrast, of the 19 patients who had no criteria present, all had infarct-vessel occlusion. There were no,differences in predictive value for inferior vs anterior infarction, time from administration of the drug from chest pain onset or plasminogen activator vs streptokinase.
Discussion
The results of the present study suggest that the clinical markers for predicting infarct-vessel recanalization after thrombolytic therapy are inadequate. Each criteria considered separately was relatively insensitive and lacked specificity. By combining criteria-if all 3 were absent or present-the predictive value was acceptable. However, all 3 criteria were present in only 5 of 37 patients (la%] who had angiographic evidence of coronary recanalization and all 3 criteria were absent in 15 of 19 patients with persistent occlusion. These findings are different from those of Lew et a1.12 Acute coronary arteriography was performed in all our patients rather than at 3 to 4 days, as in the study of Lew et a1.12 Perhaps more important, we used the coronary arteriogram rather than early peaking of creatine kinase curves to demonstrate reperfusion.
Multiple confounding variables make the clinical criteria for reperfusion unreliable. Patients often require opiate narcotics for treatment of chest pain, and these drugs may interfere with our ability to judge whether relief or improvement has occurred.13 Similarly, as myonecrosis ensues, there will be relief of pain. A decrease in ST-segment elevation may be difficult to evaluate because it typically occurs as part of evolutionary electrocardiographic changes. Finally, reperfusion arrhythmias can occur spontaneously in the early hours of infarction without reperfusion. Before the routine use of thrombolytic therapy, such rhythm disturbances were considered part of the natural history of myocardial infarction.14 There remains a critical need for a noninvasive marker of myocardial reperfusion. Such a marker could allow patients to be appropriately triaged to the coronary care unit for adjunctive therapy directed to sustaining coronary arterial patency, or to a cardiac catheterization laboratory for angiography and consideration for PTCA. If proved effective, the latter strategy has important public health implications affecting the need for regionalization of interventional cardiac care and reliance on rapid interhospital transport such as the helicopter. l5 In particular, patients at high risk, such as those with a large anterior myocardial infarct or pulmonary edema, may benefit from aggressive intervention with PTCA if intravenous thrombolysis has failed. Several markers have been proposed to detect reperfusion. However, the test for creatine kinase isoenzyme levelsI and serum myoglobin may be fraught with practical and theoretical obstacles. First, such blood tests require a turnaround time that may only provide useful information after myonecrosis is already complete. Second, there appears to be a dynamic course of infarct-artery occlusion in many patients. Angiographically, intermittent patency and occlusion is not unusual. This problem could confound evaluation of an enzymatic test directed at appropriately triaging a patient. Holter ST-segment monitoring has been used to correlate with reperfusion, but the time needed to establish the trend and analyze the data, along with the relative lack of specificity, appear to make this particular technique impractical and inaccurate. 17 
